Cognition Therapeutics annual return on equity
2022
2023
2024
2025
Cognition Therapeutics Return on Equity (ROE) Growth & History (CGTX)
Cognition Therapeutics's return on equity was −88.60% for fiscal 2025.
View full Cognition Therapeutics company overviewCognition Therapeutics annual return on equity history
| Fiscal year | Period ended | Return on equity | Change (percentage points) |
|---|---|---|---|
| 2025 | 2025-12-31 | −88.60% | +68.59 pp |
| 2024 | 2024-12-31 | −157.19% | −77.50 pp |
| 2023 | 2023-12-31 | −79.69% | −32.93 pp |
| 2022 | 2022-12-31 | −46.76% | — |
Cognition Therapeutics quarterly return on equity
Q1.22
Q2.22
Q3.22
Q4.22
Q1.23
Q2.23
Q3.23
Q4.23
Q1.24
Q2.24
Q3.24
Q4.24
Q1.25
Q2.25
Q3.25
Q4.25
Q1.26
Q2.26
| Fiscal quarter | Period ended | Return on equity | Change (percentage points) |
|---|---|---|---|
| Q2 2026 | 2026-06-30 | −12.50% | +57.29 pp |
| Q1 2026 | 2026-03-31 | −14.24% | +40.43 pp |
| Q4 2025 | 2025-12-31 | −9.44% | +37.75 pp |
| Q3 2025 | 2025-09-30 | −22.64% | +30.37 pp |
| Q2 2025 | 2025-06-30 | −69.79% | −42.64 pp |
| Q1 2025 | 2025-03-31 | −54.67% | −20.36 pp |
| Q4 2024 | 2024-12-31 | −47.20% | −16.70 pp |
| Q3 2024 | 2024-09-30 | −53.01% | −31.69 pp |
| Q2 2024 | 2024-06-30 | −27.15% | −13.68 pp |
| Q1 2024 | 2024-03-31 | −34.32% | −18.08 pp |
| Q4 2023 | 2023-12-31 | −30.49% | −17.47 pp |
| Q3 2023 | 2023-09-30 | −21.32% | −5.40 pp |
| Q2 2023 | 2023-06-30 | −13.47% | −1.05 pp |
| Q1 2023 | 2023-03-31 | −16.24% | −8.56 pp |
| Q4 2022 | 2022-12-31 | −13.03% | — |
| Q3 2022 | 2022-09-30 | −15.92% | — |
| Q2 2022 | 2022-06-30 | −12.42% | — |
| Q1 2022 | 2022-03-31 | −7.68% | — |
Cognition Therapeutics return on equity trends
Between the periods ended 2022-12-31 and 2025-12-31, Cognition Therapeutics's return on equity decreased from −46.76% to −88.60%, a change of −41.84 percentage points. The latest reported quarter, Q2 2026, shows −12.50%.
About the metric
What return on equity (ROE) means
Return on equity (ROE) measures how much net income a company generates relative to shareholders’ equity. It can help evaluate how efficiently equity capital is used, but unusually high or negative values may reflect leverage, losses, or a small equity base.
Calculation and source
How return on equity is calculated
TickerStat calculates ROE as SEC-reported net income divided by average stockholders’ equity at the beginning and end of the fiscal period. Periods with missing or non-positive average equity are omitted. Quarterly ROE uses quarterly net income and is not annualized. Fiscal periods can differ from calendar years, so exact period-end dates are included.
Review Cognition Therapeutics source filings ↗